DANA BEENSTOCK: Open Payments
NPI 1376607861 · FREEHOLD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$19,210 in 198 payments from 18 companies in 2025. Trend: 2023 $7,148 · 2024 $12,197 · 2025 $19,210
Speaker / faculty: $11,950Food & beverage: $3,788Travel & lodging: $3,234Consulting: $175Education: $63
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. | 31 | $13,105 |
| E.R. Squibb & Sons, L.L.C. | 5 | $3,234 |
| Biogen, Inc. | 28 | $635 |
| EMD Serono, Inc. | 18 | $396 |
| Novartis Pharmaceuticals Corporation | 32 | $328 |
| ABBVIE INC. | 24 | $301 |
| Amgen Inc. | 5 | $293 |
| Genentech USA, Inc. | 9 | $150 |
| Vanda Pharmaceuticals Inc. | 12 | $148 |
| Celgene Corporation | 7 | $148 |
Products named: BRIUMVI, ZEPOSIA, TYSABRI, KESIMPTA, UPLIZNA, Ocrevus Zunovo, PONVORY, BOTOX.
Industry payments across NJ — which companies pay providers there.
